RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Evaluating newly approved drugs for multidrug-resistant tuberculosis (endTB): study protocol for an adaptive, multi-country randomized controlled trial

Add to Collection
RCTs L Guglielmetti, E Ardizzoni, M Atger, E Baudin… - Trials, 2021 - Springer

Chapter : Section5, Section6
Journal Year : 2021
Cited by : 11

… of new, shortened, injectable-sparing regimens for MDR-TB … for comorbidities (eg HIV, diabetes mellitus) receive all care … inform adaptation, and possible bias introduced by changes in …..... Read More

Keywords : ['multidrugresistant tuberculosis endtb study protocol', 'adaptive multicountry randomize control trial', 'evaluate newly approve drug']
PubMed Link : https://link.springer.com/article/10.1186/s13063-021-05491-3
Google Scholar Link : https://scholar.google.com/scholar?cites=3619513056102425678&as_sdt=2005&sciodt=0,5&hl=en&num=20